Authors' Affiliations: MRC Centre for Regenerative Medicine; Human Genetics Unit, University of Edinburgh; Department of Surgery and Transplantation Medicine, Royal Infirmary of Edinburgh, Edinburgh; and Beatson Institute for Cancer Research, Glasgow, Scotland, United Kingdom.
Cancer Res. 2014 Feb 15;74(4):1005-10. doi: 10.1158/0008-5472.CAN-13-1911. Epub 2013 Dec 5.
Intrahepatic cholangiocarcinoma is a treatment refractory malignancy with a high mortality and an increasing incidence worldwide. Recent studies have observed that activation of Notch and AKT signaling within mature hepatocytes is able to induce the formation of tumors displaying biliary lineage markers, thereby raising the suggestion that it is hepatocytes, rather than cholangiocytes or hepatic progenitor cells that represent the cell of origin of this tumor. Here, we use a cholangiocyte-lineage tracing system to target p53 loss to biliary epithelia and observe the appearance of labeled biliary lineage tumors in response to chronic injury. Consequent to this, upregulation of native functional Notch signaling is observed to occur spontaneously within cholangiocytes and hepatocytes in this model as well as in human intrahepatic cholangiocarcinoma. These data prove that in the context of chronic inflammation and p53 loss, frequent occurrences in human disease, biliary epithelia are a target of transformation and an origin of intrahepatic cholangiocarcinoma.
肝内胆管癌是一种治疗难治的恶性肿瘤,具有高死亡率和全球发病率不断上升的特点。最近的研究观察到,成熟肝细胞中 Notch 和 AKT 信号的激活能够诱导形成具有胆管谱系标志物的肿瘤,从而提出这样的观点,即这种肿瘤的起源细胞是肝细胞,而不是胆管细胞或肝祖细胞。在这里,我们使用胆管细胞谱系追踪系统将 p53 缺失靶向胆管上皮,并观察到在慢性损伤下出现标记的胆管谱系肿瘤。因此,在这种模型以及人类肝内胆管癌中,观察到天然功能性 Notch 信号的上调会在胆管细胞和肝细胞中自发发生。这些数据证明,在慢性炎症和 p53 缺失的情况下(这在人类疾病中经常发生),胆管上皮是转化的靶标,也是肝内胆管癌的起源。